Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Cryoprecipitate Reversal of Opsonic $\alpha_{2}$-Surface Binding Glycoprotein Deficiency in Septic Surgical and Trauma Patients

Thomas M. Saba, Frank A. Blumenstock, William A. Scovill and Harvey Bernard
Science
New Series, Vol. 201, No. 4356 (Aug. 18, 1978), pp. 622-624
Stable URL: http://www.jstor.org/stable/1746256
Page Count: 3
  • More info
  • Cite this Item
Cryoprecipitate Reversal of Opsonic $\alpha_{2}$-Surface Binding Glycoprotein Deficiency in Septic Surgical and Trauma Patients
Preview not available

Abstract

Human opsonic $\alpha_{2}$-surface binding glyoprotein ($\alpha_{2}$SB-glycoprotein), a molecule having immunologic identity with an amino acid composition similar to cold-insoluble globulin, is concentrated in a cryoprecipitate of plasma. Septic surgical and trauma patients manifesting opsonic $\alpha_{2}$SB-glycoprotein deficiency and associated reticuloendothelial system dysfunction were treated by intravenous infusion of cryoprecipitate. This therapy restored circulating bioreactive and immunoreactive opsonin and improved their septicemia, pulmonary insufficiency, and duration of recovery. Cryoprecipitate infusion may offer a new approach to the treatment of septic injured patients in preventing multiple organ failure; measurement of immunoreactive serum opsonic $\alpha_{2}$SB-glycoprotein may provide a noninvasive index of reticuloendothelial system function and patient status during severe sepsis that follows trauma.

Page Thumbnails

  • Thumbnail: Page 
622
    622
  • Thumbnail: Page 
623
    623
  • Thumbnail: Page 
624
    624